Risk Assessment Models for Thrombosis and Anticoagulant-Related Bleeding in Ambulatory Cancer Patients.

Seminars in Thrombosis and Hemostasis
Matteo CandeloroMarcello Di Nisio

Abstract

Cancer patients have a high risk of developing venous thromboembolism and arterial thrombosis, along with an increased risk of anticoagulant-related bleeding with primary and secondary prophylaxis of cancer-associated thrombosis. Decisions on initiation, dosing, and duration of anticoagulant therapy for prevention and treatment of cancer-associated thrombosis are challenging, as clinicians have to balance patients' individual risk of (recurrent) thrombosis against the risk of bleeding complications. For this purpose, several dedicated risk assessment models for venous thromboembolism in cancer patients have been suggested. However, most of these scores perform poorly and have received limited to no validation. For bleeding and arterial thrombosis, no risk scores have been developed specifically for cancer patients, and treatment decisions remain based on clinical gestalt and rough and unstructured estimation of the risks. The aims of this review are to summarize the characteristics and performance of risk assessment scores for (recurrent) venous thromboembolism and discuss available data on risk assessment for bleeding and arterial thrombosis in the cancer population. This summary can help clinicians in daily practice to make a...Continue Reading

References

Mar 13, 1999·Archives of Internal Medicine·P M KuijerH R Büller
Dec 16, 2000·The New England Journal of Medicine·H T SørensenJ A Baron
Aug 25, 2005·Journal of Surgical Oncology·Frank A ScappaticciHerbert Hurwitz
Mar 31, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Toni K ChoueiriJoaquim Bellmunt
Sep 11, 2010·Blood·Cihan AyIngrid Pabinger
Aug 3, 2013·Blood·Jasmijn F TimpSuzanne C Cannegieter
Jul 7, 2016·American Journal of Hematology·Darko AnticBiljana Mihaljevic
Nov 25, 2016·Thrombosis and Haemostasis·Cihan AyAlexander T Cohen
Apr 21, 2017·The Oncologist·Chiara Alessandra CellaSabino De Placido
Oct 20, 2017·JAMA : the Journal of the American Medical Association·Ana Carolina AlbaGordon Guyatt
Dec 17, 2017·Journal of Thrombosis and Haemostasis : JTH·B ÜnlüH H Versteeg
Mar 25, 2018·Journal of Thrombosis and Haemostasis : JTH·P W KamphuisenUNKNOWN CATCH Investigators
Mar 29, 2018·British Journal of Cancer·Andrés J Muñoz MartínJose M Soria
Apr 24, 2018·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Andrew J LloydAgnes Y Y Lee
Sep 3, 2018·The Lancet. Haematology·Patrizia FerroniFiorella Guadagni
Dec 5, 2018·The New England Journal of Medicine·Marc CarrierUNKNOWN AVERT Investigators
Dec 21, 2018·Journal of Thrombosis and Haemostasis : JTH·Annatina Schnegg-KaufmannAnne Angelillo-Scherrer
Jan 5, 2019·Haematologica·Frits I MulderUNKNOWN CAT-prediction collaborators
Feb 21, 2019·The New England Journal of Medicine·Alok A KhoranaUNKNOWN CASSINI Investigators
Mar 29, 2019·Journal of Thrombosis and Thrombolysis·Marcello Di NisioEttore Porreca
Aug 6, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nigel S KeyAnna Falanga
Sep 8, 2019·The Lancet Oncology·Dominique FargeUNKNOWN International Initiative on Thrombosis and Cancer (ITAC) advisory panel
Oct 19, 2019·Research and Practice in Thrombosis and Haemostasis·Babak B NaviPaul Muntner
Apr 5, 2020·Clinical Lymphoma, Myeloma & Leukemia·Onur KirkizlarAhmet Muzaffer Demir

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Translational Research : the Journal of Laboratory and Clinical Medicine
Ann S KimKeith R McCrae
Thrombosis Research
Yohei Hisada, Nigel Mackman
© 2021 Meta ULC. All rights reserved